Biodegradable implant strategies for inhibition of restenosis
- 15 February 1997
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 24 (1) , 3-9
- https://doi.org/10.1016/s0169-409x(96)00478-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Polymericcarriers for regional drug therapyMolecular Medicine Today, 1995
- The basis of molecular strategies for treating coronary restenosis after angioplastyJournal of the American College of Cardiology, 1994
- Molecular biology: Insight into the causes and prevention of restenosis after arterial interventionThe American Journal of Cardiology, 1993
- Pharmacological Approaches to the Prevention of Restenosis Following AngioplastyDrugs, 1993
- The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplastyJournal of the American College of Cardiology, 1991
- A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapiesJournal of the American College of Cardiology, 1991
- Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 PatientsJournal of the American College of Cardiology, 1988
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984
- Controlled release of biologically active compounds from bioerodible polymersBiomaterials, 1980
- ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISMThe Lancet, 1960